Ankylosing Spondylitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are an adult (over 18 years old)
- You have been diagnosed with a type of inflammatory arthritis called Spondyloarthritis (SpA), confirmed using recognised medical guidelines
- Your condition is currently active, meaning you have swollen or inflamed joints, tendon inflammation, swollen fingers or toes, or significant back pain due to SpA, as confirmed by a doctor
- You are willing and able to give your signed consent to take part
- You are covered by health insurance (not a specific type called AME)
For Group 1 only (confirm with trial site):
- You have never previously been treated with biological therapies (a specific type of medication used for inflammatory conditions)
For Group 2 only (confirm with trial site):
- You have peripheral SpA or psoriatic arthritis affecting your joints (not just your spine)
- You need a joint fluid drainage procedure as part of your normal care
Who may not be able to join:
- You are under 18 years old
- You are pregnant or breastfeeding
- Your immune system is weakened for any reason
- You have previously been treated with two or more biological therapies
- You are currently taking steroid medication at a dose higher than 10 mg per day
- You are under any form of legal protection or guardianship
- You do not wish to give your consent to participate
- You have a history of alcohol or drug dependency, significant psychological difficulties, or serious other health conditions that may affect your ability to take part fully (confirm with trial site)
- You are covered by the specific health insurance type called AME
For Group 1 only:
- You have previously received any biological therapy
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33140613822
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Profiling of open chromatin regions; Profiling of transcriptome; Profiling of the genome; Profiling of cytokine expression; Single cell transcriptome analysis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.